T-cell masthead image

Beclomethasone dipropionate for the treatment of mild-to-moderate crohn’s disease: An open-label, budesonide-controlled, randomized study

Beclomethasone dipropionate for the treatment of mild-to-moderate crohn’s disease: An open-label, budesonide-controlled, randomized study

Tursi A, Giorgetti GM, Brandimarte G, et al. Beclomethasone dipropionate for the treatment of mild-to-moderate crohn’s disease: An open-label, budesonide-controlled, randomized study. Med Sci Monit. 2006; 12(6): PI29-32.

Learn More